Coronel F, García-Mena M, Martínez R
Department of Nephrology, Hospital Clinico San Carlos, Madrid, Spain.
Clin Nephrol. 2004 Feb;61(2):155-8. doi: 10.5414/cnp61155.
There have been several recent reports of pure red-cell aplasia (PRCA) mediated by anti-erythropoietin antibodies (AEA) in patients with chronic renal failure treated with recombinant human erythropoietin (EPO). Among the factors thought to trigger this mechanism is the subcutaneous administration of EPO. Despite this being the normal route of administration in patients undergoing peritoneal dialysis (PD), to date there has only been 1 described case of PRCA due to AEA in PD. Herein, we report such a case involving a patient in whom a diagnosis of anemia due to PRCA was particularly difficult to make because of concomitant rectal bleeding.
近期有几篇关于慢性肾衰竭患者接受重组人促红细胞生成素(EPO)治疗时,由抗促红细胞生成素抗体(AEA)介导的纯红细胞再生障碍性贫血(PRCA)的报道。皮下注射EPO被认为是触发这一机制的因素之一。尽管这是腹膜透析(PD)患者的常规给药途径,但迄今为止,仅有1例因AEA导致的PRCA在PD患者中的报道。在此,我们报告这样一例病例,该患者因同时存在直肠出血,诊断PRCA所致贫血尤为困难。